Analyst Consensus ?
ConsensusHold44 ratings
Bullish2352.3%
Neutral1840.9%
Bearish36.8%
Monster Beverage Corporation · MNST · FY2024 Q3 · Calendar Q4 2024
Monster’s global growth offsets U.S. softness, but near-term risks remain
The supplied analysis supports a constructive but qualified growth thesis: global category expansion, pricing, innovation, and distribution reach are positives, while U.S. softness and margin, inventory, commodity, currency, and execution risks limit confidence.
Reported After market closeNASDAQConsumer Defensive
$89.59B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$0.40
Consensus $0.43
EPS surprise
-7.0%
Reported versus consensus
Reported revenue
$2.76B
Consensus $1.91B
Revenue surprise
+44.9%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
-1.1%
Event window
SPY move
+0.4%
Same window
Abnormal move
-1.5%
Stock minus SPY
Volume
1.8×
Versus trailing sessions
Subsequent drift
-1.7%
Up to 20 sessions
MNSTSPY benchmark
Ask FN2 about MNST FY2024 Q3
Transcript, numbers and history already loaded
Why did MNST fall 1.1% after missing EPS estimates in FY2024 Q3?What changed in MNST's guidance and outlook in FY2024 Q3?Give me the bull and bear case for MNST after FY2024 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The quarter added evidence of continued global category strength and new product and geographic expansion, while highlighting U.S. demand softness, hurricane disruption, inventory reserves, higher costs, and uncertainty around the November price increase.
Guidance delta
No guidance was provided in the supplied analysis; management emphasized pricing, innovation, international expansion, and operational efficiency.
Key takeaways
- Q3 sales reached a record $1.88 billion, up modestly year over year and 4.7% on a currency-neutral basis.
- Global category momentum was strongest in EMEA, APAC, and Latin America, while the U.S. market was modestly weaker.
- Pricing, new products, geographic expansion, and the Coca-Cola bottler network remain central to the growth plan.
Management priorities
- Expand Predator and Fury in China and India.
- Launch new flavors and the Ireland AFF juice plant in early 2025.
- Use pricing, aluminum hedging, and operating efficiencies to improve margins while continuing share repurchases.
Follow MNST with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$45.73Current
$23Low
$74.11Average
$105High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 17, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Oct 5, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 7, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 7, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Aug 7, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Aug 7, 2026 |
| Deutsche Bank | Hold | Buy | Downgrade | Jul 20, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 20, 2026 |
| Stifel | Buy | Buy | Maintain | Jul 16, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 14, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jun 1, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | May 8, 2026 |
| Rothschild & Co | Buy | Neutral | Upgrade | May 6, 2026 |
| TD Cowen | Hold | Hold | Maintain | Jan 8, 2026 |
| B of A Securities | Buy | Buy | Maintain | Nov 7, 2025 |
| Roth Capital | Neutral | Neutral | Maintain | Aug 13, 2025 |
| Redburn Atlantic | Neutral | Buy | Downgrade | Jul 9, 2025 |
| Roth MKM | Neutral | Neutral | Maintain | May 14, 2025 |
| CICC | Outperform | Market Perform | Upgrade | May 12, 2025 |
| Truist Securities | Sell | Sell | Maintain | Apr 24, 2025 |
| Needham | Hold | Hold | Maintain | Feb 28, 2025 |
| HSBC | Buy | Buy | Maintain | Mar 6, 2024 |
| MKM Partners | Neutral | Neutral | Maintain | Aug 10, 2023 |
| Goldman Sachs | Buy | Buy | Maintain | May 5, 2023 |
| Wedbush | Neutral | Neutral | Maintain | Mar 30, 2023 |
| Argus Research | Buy | Buy | Maintain | Mar 21, 2023 |
| Redburn Partners | Buy | Neutral | Upgrade | Mar 6, 2023 |
| Bernstein | Outperform | Market Perform | Upgrade | May 18, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 18, 2022 |
| Jefferies | Hold | Buy | Downgrade | Oct 13, 2021 |
| Guggenheim | Buy | Neutral | Upgrade | Mar 20, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Feb 28, 2020 |
| Cowen & Co. | Market Perform | Outperform | Downgrade | Oct 17, 2019 |
| Macquarie | Neutral | Outperform | Downgrade | Apr 1, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | Sep 18, 2018 |
| Susquehanna | Negative | Neutral | Downgrade | Nov 20, 2017 |
| Bank of America | Neutral | Neutral | Maintain | Mar 22, 2016 |
| CLSA | Buy | Outperform | Maintain | Feb 26, 2016 |
| ISI Group | Buy | Buy | Maintain | Sep 22, 2014 |
| Longbow Research | Neutral | Underperform | Upgrade | Aug 8, 2014 |
| BTIG Research | Buy | Buy | Maintain | Jun 19, 2014 |
| Northcoast Research | Sell | Sell | Maintain | Aug 23, 2013 |
| Gabelli & Co. | Hold | Buy | Downgrade | May 9, 2013 |
| ValuEngine | Strong Buy | Strong Buy | Maintain | Nov 27, 2012 |
| Canaccord Genuity | Hold | Hold | Maintain | May 10, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $45.73. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Deutsche Bank | Analyst unavailable | $100 | $90.36 | +118.7% | Aug 10, 2026 |
| RBC Capital | Nik Modi | $97 | $94.65 | +112.1% | Aug 5, 2026 |
| BMO Capital | Andrew Strelzik | $95 | $97.5 | +107.7% | Jul 20, 2026 |
| Deutsche Bank | Steve Powers | $98 | $97.5 | +114.3% | Jul 20, 2026 |
| UBS | Analyst unavailable | $104 | $99.59 | +127.4% | Jul 16, 2026 |
| Wells Fargo | Chris Carey | $105 | $96.92 | +129.6% | Jul 8, 2026 |
| Bernstein | Analyst unavailable | $95 | $92.03 | +107.7% | Jun 11, 2026 |
| Morgan Stanley | Dara Mohsenian | $103 | $88.08 | +125.2% | Jun 1, 2026 |
| Morgan Stanley | Analyst unavailable | $100 | $86.29 | +118.7% | May 10, 2026 |
| Evercore ISI | Analyst unavailable | $95 | $85.84 | +107.7% | May 8, 2026 |
| Redburn Partners | Charlie Higgs | $90 | $75.8 | +96.8% | May 6, 2026 |
| RBC Capital | Analyst unavailable | $86 | $76.19 | +88.1% | Apr 9, 2026 |
| Jefferies | Analyst unavailable | $100 | $77.52 | +118.7% | Mar 11, 2026 |
| Seaport Global | Analyst unavailable | $88 | $85.3 | +92.4% | Feb 27, 2026 |
| RBC Capital | Analyst unavailable | $88 | $84.76 | +92.4% | Feb 24, 2026 |
| Deutsche Bank | Analyst unavailable | $88 | $83.22 | +92.4% | Feb 20, 2026 |
| Argus Research | Analyst unavailable | $95 | $81.42 | +107.7% | Jan 27, 2026 |
| Morgan Stanley | Analyst unavailable | $96 | $82 | +109.9% | Jan 26, 2026 |
| BNP Paribas | Analyst unavailable | $77 | $77.91 | +68.4% | Jan 16, 2026 |
| UBS | Peter Grom | $84 | $76.95 | +83.7% | Jan 14, 2026 |
| Wells Fargo | Chris Carey | $86 | $75.75 | +88.1% | Jan 5, 2026 |
| Morgan Stanley | Analyst unavailable | $87 | $77.66 | +90.2% | Dec 23, 2025 |
| Stifel Nicolaus | Matthew Smith | $82 | $72.49 | +79.3% | Dec 12, 2025 |
| Roth Capital | Analyst unavailable | $70 | $73.98 | +53.1% | Dec 3, 2025 |
| BMO Capital | Andrew Strelzik | $73 | $74.71 | +59.6% | Dec 3, 2025 |
| Piper Sandler | Michael Lavery | $85 | $74.71 | +85.9% | Dec 3, 2025 |
| Wells Fargo | Chris Carey | $83 | $74.71 | +81.5% | Dec 3, 2025 |
| RBC Capital | Nik Modi | $81 | $74.99 | +77.1% | Dec 1, 2025 |
| Morgan Stanley | Dara Mohsenian | $81 | $72.28 | +77.1% | Nov 7, 2025 |
| Jefferies | Kaumil Gajrawala | $79 | $66.48 | +72.8% | Nov 4, 2025 |
| Stifel Nicolaus | Matthew Smith | $78 | $69.52 | +70.6% | Oct 24, 2025 |
| RBC Capital | Nik Modi | $75 | $69.57 | +64.0% | Oct 10, 2025 |
| UBS | Analyst unavailable | $72 | $68.15 | +57.4% | Oct 8, 2025 |
| RBC Capital | Nik Modi | $68 | $65.26 | +48.7% | Aug 8, 2025 |
| Wells Fargo | Chris Carey | $73 | $60.8 | +59.6% | Aug 8, 2025 |
| Piper Sandler | Michael Lavery | $74 | $64.69 | +61.8% | Aug 8, 2025 |
| Morgan Stanley | Dara Mohsenian | $70 | $63.69 | +53.1% | Jun 12, 2025 |
| Goldman Sachs | Bonnie Herzog | $67 | $62.87 | +46.5% | May 23, 2025 |
| UBS | Analyst unavailable | $57 | $54.65 | +24.6% | Mar 2, 2025 |
| Morgan Stanley | Analyst unavailable | $60 | $54.65 | +31.2% | Feb 28, 2025 |
| Deutsche Bank | Steve Powers | $61 | $52.3 | +33.4% | Nov 1, 2024 |
| Goldman Sachs | Bonnie Herzog | $63 | $45.26 | +37.8% | Aug 8, 2024 |
| BMO Capital | Andrew Strelzik | $54 | $45.32 | +18.1% | Aug 8, 2024 |
| Piper Sandler | Michael Lavery | $46 | $44.2 | +0.6% | Aug 8, 2024 |
| Jefferies | Kaumil Gajrawala | $60 | $50.53 | +31.2% | Aug 8, 2024 |
| RBC Capital | Nik Modi | $64 | $49.95 | +40.0% | Jul 1, 2024 |
| BNP Paribas | Kevin Grundy | $48 | $49.09 | +5.0% | Jun 24, 2024 |
| RBC Capital | Nik Modi | $65 | $48.52 | +42.1% | Jun 14, 2024 |
| Goldman Sachs | Bonnie Herzog | $66 | $48.72 | +44.3% | Jun 14, 2024 |
| Deutsche Bank | Steve Powers | $63 | $48.72 | +37.8% | Jun 14, 2024 |
| Jefferies | Kaumil Gajrawala | $61 | $49.77 | +33.4% | Jun 13, 2024 |
| Roth Capital | Sean McGowan | $56 | $51.16 | +22.5% | Jun 12, 2024 |
| BMO Capital | Andrew Strelzik | $56 | $54.86 | +22.5% | May 3, 2024 |
| Piper Sandler | Michael Lavery | $59 | $54.52 | +29.0% | May 3, 2024 |
| Truist Financial | Bill Chappell | $46 | $54.33 | +0.6% | Apr 25, 2024 |
| Piper Sandler | Michael Lavery | $50 | $50.3 | +9.3% | Oct 24, 2023 |
| Wedbush | Gerald Pascarelli | $23.75 | $22.76 | -48.1% | Oct 10, 2022 |
| UBS | Peter Grom | $24.75 | $22.54 | -45.9% | Aug 24, 2022 |
| Roth Capital | Sean McGowan | $25 | $24.35 | -45.3% | Jul 13, 2022 |
| Stifel Nicolaus | Mark Astrachan | $26.25 | $22.96 | -42.6% | Jun 23, 2022 |
| Morgan Stanley | Dara Mohsenian | $29.25 | $22.03 | -36.0% | Jun 18, 2022 |
| RBC Capital | Nik Modi | $25 | $22 | -45.3% | Jun 14, 2022 |
| Bernstein | Callum Elliott | $27.5 | $22.31 | -39.9% | May 18, 2022 |
| Stifel Nicolaus | Mark Astrachan | $25.75 | $18.3 | -43.7% | Mar 13, 2022 |
| Citigroup | Wendy Nicholson | $24.5 | $21.14 | -46.4% | Feb 25, 2022 |
| Credit Suisse | Kaumil Gajrawala | $27.5 | $20.32 | -39.9% | Feb 18, 2022 |
| Wells Fargo | Chris Carey | $25 | $20.81 | -45.3% | Feb 16, 2022 |
| Goldman Sachs | Bonnie Herzog | $27.25 | $24.44 | -40.4% | Jan 4, 2022 |
| Morgan Stanley | Dara Mohsenian | $27.75 | $22.91 | -39.3% | Nov 5, 2021 |
| Jefferies | Kevin Grundy | $23 | $21.33 | -49.7% | Oct 13, 2021 |
| Truist Financial | Bill Chappell | $28.75 | $22.81 | -37.1% | May 7, 2021 |
Track every rating change on MNST the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationMonster Beverage Corporation is a global entity primarily involved in the innovation, marketing, sale, and distribution of energy beverages and concentrates. Its business operations are categorized into three main divisions: Monster Energy Drinks, Strategic Brands, and a segment designated as "Other." The company boasts an extensive product portfolio, encompassing a wide array of carbonated energy drinks, alongside various non-carbonated options. These include ready-to-drink iced teas, lemonades, diverse juice cocktails, single-serving juices, and fruit beverages. Additionally, their offerings extend to ready-to-drink dairy and coffee-based concoctions, specialized sports drinks, single-serve still waters, and a selection of sodas described as natural, sparkling juices, and flavored sparkling beverages. Monster Beverage distributes its products through a comprehensive network, supplying bottlers and full-service beverage distributors.…
Historical context
All MNST earningsLatest beats and misses
Who reports nextBeat on EPS
Get the MNST recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-10T18:38:36.707185+00:00
- Polygon adjusted daily market bars · 2026-10-17T11:10:46.586928+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-17T11:10:46.584105+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-17. For educational purposes only; not investment advice.